News

 

At AseBio, we follow the latest news in the biotechnology sector and pass the highlights on to you. You can use the search engine to find news articles we’ve written, contributed by our members or from other stakeholders in the sector. And they are also organised into categories to help you find the topics you’re interested in easily.

Search engine
Científicos analizando muestras en un laboratorio
Next-generation CAR-T therapies for pediatric sarcomas: Biotechnological advances show promising results
Healthcare
The CIBER Cancer Area (CIBERONC) is developing advanced cellular therapies targeting pediatric…
AseBio - CIBER
Maria Terrades Palomar – CEO del PCB (Parc Científic de Barcelona).
Maria Terrades: "Scientific knowledge, cutting-edge research and entrepreneurial vision converge at the PCB, facilitating collaboration and knowledge transfer"
Corporate
In 2024, the Parc Científic de Barcelona (PCB) reached full occupancy of its facilities and is…
Partners - GENESIS Biomed
Ignacio Sancho-Martinez CEO y co-fundador
#NewAseBioMember | "AseBio is a key player in Spain's biotech ecosystem"
Corporate
Meet our new member  Inbistra. We spoke with Ignacio Sancho-Martinez CEO y co-fundadorr
AseBio - INBISTRA
Accelerating molecular discovery
Accelerating molecular discovery using an in silico design platform
Healthcare · Access to innovation · Drug discovery · Innovative drugs · Advanced therapies · Industrial biotechnology
Join our free event on Tuesday, July 8th at the Parque Científico de Barcelona for an extended…
Lander Elkoro, Market Manager Formulation & Biopharma Iberia de IMCD
#NewAseBioAlly | "AseBio is a key reference point in Spain’s biotechnology ecosystem"
Corporate
Meet IMCD, our new Ally. We spoke with Lander Elkoro, Market Manager Formulation…
Equipo de ADmit
ADmit Therapeutics Relocates to New State-of-the-Art Facilities Within the Almirall’s Innovation Hub "The Hive"
Healthcare
Biotech company ADmit Therapeutics has announced its move to new state-of-the-art facilities at “…
Partners - ADmit Therapeutics
logo Trimerbody Pharma
Name change from Leadartis and launch of new website
Corporate
Trimerbody Pharma, a clinical-stage biopharmaceutical company developing proprietary therapeutic…
Pablo Pelegrin
How to Secure the EIC Transition Grant: 6 Key Lessons from a Spanish Success Story
Access to innovation
The biotechnology company Viva In Vitro Diagnostics shares its experience during the CDTI and FECYT…
Partners - VIVA IN VITRO
Proyecto ShapingBio
AseBio Drives European Debate on Bioeconomy with the Organization of the "ShapingBio Summit" in Brussels
Bioeconomy · EU projects
In collaboration with the European ShapingBio consortium, of which AseBio is a member, the event…